CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $687,000 | +64.4% | 20,327 | +13.6% | 0.00% | +100.0% |
| Q1 2021 | $418,000 | -18.7% | 17,889 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $514,000 | +38.2% | 17,842 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $372,000 | -25.2% | 18,354 | +11.0% | 0.00% | 0.0% |
| Q2 2020 | $497,000 | +41.2% | 16,534 | +47.8% | 0.00% | 0.0% |
| Q1 2020 | $352,000 | -22.8% | 11,190 | +15.6% | 0.00% | 0.0% |
| Q4 2019 | $456,000 | +623.8% | 9,679 | -0.8% | 0.00% | – |
| Q3 2019 | $63,000 | -47.9% | 9,761 | -0.7% | 0.00% | – |
| Q2 2019 | $121,000 | -11.7% | 9,828 | -2.7% | 0.00% | -100.0% |
| Q1 2019 | $137,000 | +1145.5% | 10,101 | +280.0% | 0.00% | – |
| Q4 2018 | $11,000 | -38.9% | 2,658 | -0.8% | 0.00% | – |
| Q3 2018 | $18,000 | – | 2,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |